ArticleScientific reports2024
In-situ upgrading of Egyptian heavy crude oil using matrix polymer carboxyl methyl cellulose/silicate graphene oxide nanocomposites.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- In Situ Heavy Crude Oil Upgrading via Catalytic Aquathermolysis with a Nickel-Based Catalyst Deposited Over a Rock Matrix.ACS omega · 2026Article
- Enhanced oil recovery from sandstone reservoir using cationic hyperbranched polyamidoamine dendrimer surfactant flooding under real reservoir conditions.Scientific reports · 2025Article
- Experimental investigation of CTAB modified clay on oil recovery and emulsion behavior in low salinity water flooding.Scientific reports · 2025Article
- Experimental study on the simultaneous effect of smart water and clay particles on the stability of asphaltene molecule and emulsion phase.Scientific reports · 2025Article
- Synthesis and evaluation of amino acid ionic liquid for enhanced oil recovery: experimental and modeling simulation studies.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study delves into catalytic aquathermolysis to enhance the economic viability of heavy oil production by in-situ upgrading technique. It is known that introducing nanocatalysts would promote the aquathermolysis reaction. Therefore, in this study, the effect of matrix polymer carboxyl methyl cellulose/silicate graphene oxide nanocomposites (CSG1 and CSG2) in the catalytic aquathermolysis of Egyptian heavy crude oil was studied. Characterization techniques including Fourier-transform infrared (FTIR), X-ray diffraction (XRD), Dynamic light scattering (DLS), Brunauer-Emmett-Teller (BET) surface area analysis, Scanning electron microscopy (SEM), and thermogravimetric analysis (TGA) were used to evaluate the structure of the synthesized nanocomposites. Results reveal CSG2 has higher crystallinity and superior dispersion compared to CSG1, and both exhibited a good stability in aqueous suspensions. CSG2 enriched with graphene oxide, demonstrates superior thermal stability, suitable for high-temperature applications such as catalytic aquathermolysis process. Single factor and orthogonal tests were used to assess the catalytic aquathermolysis performance of the prepared nanoparticles. The obtained results revealed that the optimum conditions to use CSG1 and CSG2 are 40% water concentration, 225 °C temperature, and 0.5 wt% catalyst percentage. Where, CSG2 showed better viscosity reduction (82%) compared to CSG1 (62%), highlighting its superior performance in reducing the viscosity of heavy oil. Numerical results from SARA analysis, gas chromatography, and rheological testing confirmed the catalytic aquathermolysis's efficacy in targeting asphaltene macromolecules and producing lighter hydrocarbon fractions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.